The Russian Federal Medical Biological Agency (FMBA) has completed preclinical studies of a COVID-19 vaccine, FMBA head Veronika Skvortsova said on Thursday
MOSCOW (Pakistan Point News / Sputnik - 15th April, 2021) The Russian Federal Medical Biological Agency (FMBA) has completed preclinical studies of a COVID-19 vaccine, FMBA head Veronika Skvortsova said on Thursday.
"Preclinical studies of a vaccine against SARS-COV-2 are almost finished," Skvortsova said at the final board of the FMBA, adding that the vaccine targets the conservative, low-variable portions of the virus and induces the development of three types of cellular immunity.
